The NTI/Dolce strains have unique properties compared to CBD alone.

The Dolce Cann Global cannabis strains contain naturally low levels (<0.3%) THC, with high levels of CBD-A, CBG, CBN, CBD-B and CBD-P.

Preclinical studies have demonstrated that NTI/Dolce strains (<0.3% THC):

  • Very high levels of CBD-A (primary active) – studies have confirmed that CBD-A up to 1,000 times more potent in regulating inflammation in chemotherapy patients than CBD alone.
  • Recent studies have indicated that CBD-A can cross the blood-brain barrier.
  • Regulate and supress inflammation by acting on Arginase1, powerful anti-inflammatory enzymes and therefore potential to be a powerful anti-inflammatory agent.
  • Up-regulating and modulation of the of beta-tubulin protein, an essential protein in the maintenance and healthy survival of brain cells.
  • Suppress and modulate the activity of iNOS – which is directly involved in the complex cytokine pathways relating to immunity and natural defence mechanisms.
  • Very high levels of CBD-A (primary active) – studies have confirmed that CBD-A up to 1,000 times more potent in regulating inflammation in chemotherapy patients than CBD alone.
  • Recent studies have indicated that CBD-A can cross the blood-brain barrier.
  • Regulate and supress inflammation by acting on Arginase1, powerful anti-inflammatory enzymes and therefore potential to be a powerful anti-inflammatory agent.
  • Up-regulating and modulation of the of beta-tubulin protein, an essential protein in the maintenance and healthy survival of brain cells.
  • Suppress and modulate the activity of iNOS – which is directly involved in the complex cytokine pathways relating to immunity and natural defence mechanisms.